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WDR34 Mutations that Cause Short-Rib Polydactyly
Syndrome Type III/Severe Asphyxiating Thoracic
Dysplasia Reveal a Role for the NF-kB Pathway in Cilia
Ce´line Huber,1,8 Sulin Wu,2,8 Ashley S. Kim,2 Sabine Sigaudy,3 Anna Sarukhanov,2 Vale´rie Serre,1
Genevieve Baujat,1 Kim-Hanh Le Quan Sang,1 David L. Rimoin,4,5 Daniel H. Cohn,2,4,6
Arnold Munnich,1 Deborah Krakow,2,4,7,9 and Vale´rie Cormier-Daire1,9,*
Short-rib polydactyly (SRP) syndrome type III, or Verma-Naumoff syndrome, is an autosomal-recessive chondrodysplasia characterized
by short ribs, a narrow thorax, short long bones, an abnormal acetabulum, and numerous extraskeletal malformations and is lethal in
the perinatal period. Presently, mutations in two genes, IFT80 and DYNC2H1, have been identified as being responsible for SRP type III.
Via homozygosity mapping in three affected siblings, a locus for the disease was identified on chromosome 9q34.11, and homozygosity
for threemissensemutations inWDR34were found in three independent families, as well as compound heterozygosity for mutations in
one family. WDR34 encodes a member of the WD repeat protein family with five WD40 domains, which acts as a TAK1-associated
suppressor of the IL-1R/TLR3/TLR4-induced NF-kB activation pathway. We showed, through structural modeling, that two of the three
mutations altered specific structural domains of WDR34. We found that primary cilia in WDR34 mutant fibroblasts were significantly
shorter than normal and had a bulbous tip. This report expands on the pathogenesis of SRP type III and demonstrates that a regulator of
the NF-kB activation pathway is involved in the pathogenesis of the skeletal ciliopathies.The short-rib polydactyly (SRP) group of skeletal dysplasias
falls within the ciliopathy spectrum of disorders. This
group includes four perinatal lethal conditions (SRP types
I–IV) and two other similar skeletal disorders, Ellis-van Cre-
veld (EVC [MIM 225500]) syndrome and asphyxiating
thoracic dysplasia (ATD [MIM 208500, MIM 611263,
MIM 613091, MIM 613819, MIM 614376]), all inherited
as autosomal-recessive disorders. Ellis-van Creveld syn-
drome is usually a nonlethal skeletal disorder associated
with a long narrow chest, short stature, atrial septal de-
fects, oral frenulum, and polydactyly. ATD is characterized
by respiratory insufficiency at birth and long-term survi-
vors are affected by retinal degeneration and cystic renal
and liver abnormalities. In ATD, increased lethality can
result from pulmonary, renal, and liver failure. ATD is
phenotypically related to short-rib polydactyly syndrome
type III (SRP type III [MIM 263510]), which is also known
as Verma-Naumoff syndrome. Indeed, both disorders share
similar radiological features including short ribs and a
trident-shaped acetabular roof of the pelvis. However, in
SRP type III, the radiographic abnormalities are more pro-
found with very shortened tubular bones with both round
and laterally spiked metaphyseal ends as well as polydac-
tyly.1,2 SRP type III is uniformly lethal as a result of pulmo-
nary hypoplasia and other concomitant organ system
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926 The American Journal of Human Genetics 93, 926–931, NovembMutations in a gene encoding a protein involved in
intraflagellar transport (IFT), IFT80 (MIM 611177), have
been identified in 3/39 individuals with ATD.3 We also
identified IFT80 mutations in one SRP type III case, sup-
porting the idea that ATD and SRP type III can be allelic
with variable severity.4 More recently mutations in cyto-
plasmic dynein 2 heavy chain 1 (DYNC2H1 [MIM
603297]) have been identified in cases affected either
with SRP type III or ATD.5,6 DYNC2H1 is a component of
the cytoplasmic dynein complex and is directly involved
in transport along microtubules via its large motor
domain. These previous molecular and phenotypic data
support the fact that SRP type III and ATD can be allelic
and both demonstrate locus heterogeneity. The proposed
functions of the identified genes confirm that the SRP skel-
etal dysplasia group belongs to the ciliopathy spectrum of
disease.5
Under an approved human subjects protocol, DNA sam-
ples were collected from 15 SRP type III cases, in accor-
dance with the ethical standards of the responsible
committee on human experimentation (institutional and
national) and proper informed consent was obtained. We
identified homozygosity for a mutation in IFT80 in one
family4 and mutations in DYNC2H1 in three other fam-
ilies.5,6 Among the 11 remaining cases, we excluded
mutations in IFT80 and DYNC2H1 and focused on aParis Cite´, Institut Imagine, Hoˆpital Necker Enfants Malades (AP-HP), Paris
f Medicine at UCLA, University of California at Los Angeles, Los Angeles,
HU de Marseille, Hoˆpital de la Timone (AP-HM), Marseille 13385, France;
ngeles, CA 90048, USA; 5Department of Pediatrics, David Geffen School of
90095, USA; 6Department of Molecular Cell and Developmental Biology,
artment of Human Genetics, David Geffen School of Medicine at UCLA,
y of Human Genetics. All rights reserved.
er 7, 2013
Figure 1. Clinical and Radiological
Features of Individuals 1 and 2 in Family 1
Clinical and radiological features of the
case 1. Male deceased at day 7 of respira-
tory distress.
(A) Note the short and narrow thorax,
short limbs, and brachydactyly.
(B) Note the long and narrow thorax with
short ribs.
(C–E, G) Upper and lower limbs: Note the
shortened tubular bones, round meta-
physeal ends with lateral spike, and the
delayed bone age.
(DandE)Hands and feet:Note roundmeta-
physeal ends with lateral spikes of square
and thickset metatarsus and phalanx and
the poor mineralization of phalanx.
(F) Note the trident aspect of the acetab-
ular roof (arrow).consanguineous Algerian family with three affected indi-
viduals. The first affected individual was diagnosed with
SRP type III or severe asphyxiating thoracic dysplasia
(ATD) by ultrasound at 23 weeks because of the findings
of micromelia, curved femurs, and short thorax. The pro-
band died on day 7 of life resulting from respiratory insuf-
ficiency and abnormal skeletal findings were confirmed by
postnatal radiographs (Figure 1). The second case was a
suspected recurrence and the pregnancy was terminated
at 26 weeks of gestation. The third case was diagnosed at
20 weeks of gestation and was stillborn at 42 weeks of
gestation.
We performed genome-wide homozygosity mapping
with (1) a 4 cM average marker density (1,000 markers,
deCODE genetics) on DNA samples from the three affected
individuals and (2) GeneChip HumanMapping 250K NspI
arrays (Affymetrix) on DNA samples from two of the
affected individuals. A single region of homozygosity
shared by the three individuals was identified on chromo-
some 9. With the MERLIN program, the maximum LOD
score was Z ¼ 2.4 (q ¼ 0) for the region delimited by the
markers at loci D9S1819 and D9S1847. Analysis of SNP
genotypes delineated the critical region of homozygosity;
the centromeric boundary defined by SNP_A-4229219
(rs2798429) and the telomeric boundary by SNP_A-
2284253 (rs10114591) (9q34.11, 3.6 Mb) (Figure S1 avail-
able online). This region contains 94 genes, and among
them, 33 genes referenced in the cilia database (cildb v.2)
were considered as candidate genes. After excluding muta-
tions in ODF2 (outer dense fiber protein 2) (MIM 602015)
by direct sequencing, we considered WD repeat-contain-
ing protein 34 (WDR34 [MIM 613363], NCBI accession
number NM_052844.3). We performed direct Sanger
sequence analysis (oligonucleotide sequences provided
on request) and identified homozygosity for a missense
mutation in the three affected cases (ex7, c.1022C>TThe American Journal of Human Gen[p.Ala341Val]) (Table 1, Figure 2).
The mutation was not identified
among 242 control chromosomes.With the use of the PolyPhen web program, the conse-
quence of this mutation was predicted as benign. However,
the SIFT web program (Sorting Intolerant From Tolerant)
predicted the substitution at position 341 from Ala to Val
to affect protein function with a score of 0.02.
Absence of any tissue to further study the consequences
of the predicted mutation prompted us to perform
whole-exome analysis on one of the affected individuals
to determine whether other mutations in the region of
homozygosity could be responsible for the disorder. Across
the exome, there were 22,165 variants in 10,359 genes.
Excluding variants listed in dbSNP and UTR, ncRNA,
synonymous, and heterozygote variants narrowed the
number of variants to 22 in 15 genes present in the homo-
zygous state. Among those, four homozygous variants in
four genes encoded ciliary proteins: VPS10 (vacuolar pro-
tein sorting 10 [MIM 602005]), DCLK2 (doublecortin like
kinase 2 [MIM 613166]), SPTBN5 (spectrin beta non eryth-
rocytic 5 [MIM 605916]), and WDR34. Finally, in the re-
gion of homozygosity on chromosome 9, there was only
one homozygous variant, the c.1022C>T change previ-
ously identified by direct sequencing of WDR34. This
homozygous change was absent from data sets including
dbSNP129, the 1000 Genomes Project, and in-house
exome data.
We then combined candidate gene sequencing of
WDR34 and whole-exome analysis in 30 independent
cases with the ATD/SRP type III spectrum phenotype.
In two individuals (both of whom had SRP type III)
from consanguineous families, homozygosity for muta-
tions in exons 7 and 8 (one in each individual) were iden-
tified (ex7 c.1061C>T [p.Thr354Met]; ex8 c.1339C>T
[p.Arg447Trp]) (Table 1, Figure 2) The mutations cosegre-
gated with the disease in each family and were not identi-
fied among 220 control chromosomes. In an indepen-
dent family with a proband (R00-326) affected by ATD,etics 93, 926–931, November 7, 2013 927
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928 The American Journal of Human Genetics 93, 926–931, Novembcompound heterozygosity for the following muta-
tions were identified: ex8 c.1340G>T, p.Arg447Gln, and
c.9822T>G. The mutations segregated within the family.
A source of RNA was not available from the affected indi-
vidual to confirm the predicted consequence of the intron
6 splice site mutation. Interestingly, the same arginine,
p.447, was substituted in the homozygous and heterozy-
gous state to methionine and glutamine, respectively.
These changes were predicted as possibly and probably
damaging by the PolyPhen and SIFT web programs,
respectively.
WDR34 encodes aproteinof 536 aminoacids that is high-
ly conserved in evolution, with human andmouseWDR34
sharing 83% identity (Ensembl). The expression pattern of
mouse Wdr34 mRNA shows that the gene is ubiquitously
expressed in all examined tissues, including brain, thymus,
heart, lung, liver, spleen, kidney, testis, and intestine.7 It is
primarily localized within the cytoplasm in 293-Flag-
WDR34-transfected HEK293 cells.7 It is a member of the
WD repeat protein family with fiveWD40 domains (details
in Figure 2).WD40 repeats areminimally conserved regions
of approximately 40 amino acids, typically bracketed by
Gly-His and Trp-Asp (GH-WD) and facilitate formation of
heterotrimeric or multiprotein complexes. These proteins
are involved in intracellular trafficking, cargo recognition,
and protein binding.8,9 In coat proteins (such as COPI,
COPII, and clathrin), they are essential for vesicular cage
formation.10
Many WD40 domain-containing proteins have been
previously implicated in the ciliopathies and specifically
in disorders with skeletal abnormalities. Indeed, mutations
in IFT80 (also called WDR56) are responsible for the ATD/
SRP type III spectrum; mutations inWDR35 (MIM 613602)
and WDR10 (also called IFT122) (MIM 606045) produce
Sensenbrenner syndrome (MIM 218330), which is charac-
terized by craniosynostosis and facial, ectodermal, and
skeletal anomalies,11–15 and WDR35 mutations have
been found in an unclassified form of SRP.16 Finally, muta-
tions in WDR19 (also called IFT144) (MIM 608151) have
been identified in Sensenbrenner syndrome, ATD, and
nephronophthisis (NPHP [MIM 256100]).17
WD40 repeats are configured into b strands and turns,
referred to as a bladed beta-propeller folded structure.
To determine the effect of the mutations (p.Ala341Val,
p.Thr354Met, p.Arg447Trp) on this structure, we under-
took homology modeling of the WDR34 mutations.
Although a three-dimensional structure has not been deter-
mined forWDR34, the 2.50 A˚ coordinate set for the yeast a/
b’-COP subcomplex of the COPI vesicular coat (PDB acces-
sion number 3mkq),18 a known beta-propeller folded struc-
ture, was used as a template for modeling the human
WDR34 protein. Using the Swiss-Model program18 in the
automated mode, the three-dimensional structure of
human WDR34 protein (residues 210–515) was compared
with residues 1–301 of the yeast b’-COP N-terminal b-pro-
peller. The predicted structures (Figure S2) were visualized
with the Swiss-Pdb Viewer 3.7. The yeast b’-COPer 7, 2013
Figure 2. Location of the WDR34 Mutations
Location of the WDR34 mutation and the five WD40-repeat-containing domains.N-terminal b-propeller is characterized by a regular and
compact structure involving short connecting loops be-
tween the b strands at both axial ends of the b-propeller.Figure 3. The p.Thr354Met and p.Arg447Trp Substitutions
Produce Abnormal Primary Cilia in Fibroblasts
(A) Control fibroblast showing the primary cilium. Blue (DAPI)
labels the nucleus, red (acetylated tubulin) labels the cilium, and
yellow labels the basal body.
(B and C) Fibroblasts from affected individuals R97-375 (B) and
R07-106 (C), showing statistically significantly shorter cilia. The
arrow in (B) identifies the bulbous tip of the cilium.
(D) Bar graph showing variation in cilia length resulting from
WDR34 mutations. n ¼ 10. SD for control 0.43, R97-375 SD,
0.48, p < 0.0008 relative to control, SD for R07-106, 0.52, p <
0.0002 relative to control.
The AmericanThe effect is to create relatively flat axial ends, which are
important for formation of interactions at the triskelion
(three arms) center. At the triskelion center, the b’-COP sub-
units associate through pairwise interactions involving a
small, circumscribed area of the axial end of oneN-terminal
b-propeller and the sides of the adjacent b-propeller. The
p.Thr354Met missense substitution is located in an area
that is predicted to be important for interactions at the
triskelion center, suggesting that the mutation might alter
the configuration of the propellers. The precise function
of WDR34 in vesicle formation is unknown, so it is not
possible to predict the functional impact of the mutation.
The p.Arg447Trp substitution is predicted to disrupt the
fourth WD40 repeat, which may influence cargo binding,
but the functional impact for p.Ala341Val substitution
was not clear from this analysis.
To further understand the effect ofWDR34 substitutions
on cilia morphology, we showed that the structure of the
cilia in cultured fibroblasts from affected individuals in
two of the families (R97-375, p.Thr354Met and R07-106,
p.Arg447Trp) appeared subjectively shorter with a bulbous
tip (Figure 3), as observed in DYNC2H1 mutant cultured
chondrocytes, suggesting a defect in cytoskeletal microtu-
bule architecture with an abnormal elongation and/or
maintenance of the axoneme by IFT to form the mature
primary cilium.6 These findings may support a role of
WDR34 in retrograde intraflagellar transport. The mean
cilia length was 2.63 5 0.44 mm for R97-375, 1.28 5
0.23 mm for R07-106, and 3.74 mm5 0.63 for control cells.
Student’s t test analysis showed that cilia from both SRP
cell lines were statistically significantly shorter than con-
trol (p < 0.05). As previously shown, WDR34 is a cyto-
plasmic protein and our observation of similar localization
of the protein between control and diseased fibroblastsJournal of Human Genetics 93, 926–931, November 7, 2013 929
Figure 4. Localization of WDR34 Protein
in Control and R97-375 Cultured Fibro-
blasts
Control fibroblasts (A–C) and R97-375 fi-
broblasts (D–F) showing localization of
WDR34 (A, D), acetylated tubulin (B, E),
and overlapping expression (C, F) (blue,
DAPI, nucleus).may suggest that the mutations do not lead to mislocaliza-
tion or absence of the protein (Figure 4).
WDR34has been implicated in the immune response as a
negative regulator of the IL-1R/TLR3/TLR4-induced NF-kB
activation pathway, functioning by sequestering TAK1,
TAB2, and TRAF6 by binding to its WD domains.7 We
further hypothesize that the mutations identified in SRP
type III individuals may disturb the stability or interaction
of WDR34 with these proteins. This is based on findings
that overexpression of WDR34 leads to diminished TAK1
phosphorylation7 and suggests that enhanced TAK1 activ-
itymay contribute to the cellular phenotype in the affected
individuals with WDR34 substitutions resulting from par-
tial loss of function. It has also been recently demonstrated
that the cilium and the regulation of its structure and func-
tion are of fundamental importance in inflammation.19 In
bovine primary chondrocytes, interleukin-1 (IL-1b and
IL-1a) exposure increases pre-existing primary cilia length.
This elongation occurred via protein kinases: cAMP-acti-
vated protein kinase A (PKA), protein kinase C (PKC), and
MAP mitogen-activated protein kinases MEK-ERK. More-
over, adenylate cyclase (cAMP) levels and G protein sub-
units Gai also regulate chondrocyte cilia length via PKA,
but independent of IL-1, implicating complex immune
regulation of cilia length.19
The identification of WDR34 mutations in four distinct
families with SRP type III/severe ATD demonstrates that
a negative regulator of the IL-1R/TLR3/TLR4-induced
NF-kB activation pathway is involved in the pathogenesis
of the skeletal ciliopathies. Our findings of abnormal
cilia with bulbous distal tip further support the role of
WDR34 in retrograde intraflagellar transport.Supplemental Data
Supplemental Data include two figures and can be found with this
article online at http://www.cell.com/AJHG/.930 The American Journal of Human Genetics 93, 926–931, NovembAcknowledgments
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